Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 30;16(9):5643-5649.
doi: 10.21037/jtd-24-784. Epub 2024 Sep 11.

Immediate change following valve deployment in left ventricular systolic and diastolic functions in transcatheter aortic valve replacement: a retrospective cohort study

Affiliations

Immediate change following valve deployment in left ventricular systolic and diastolic functions in transcatheter aortic valve replacement: a retrospective cohort study

Yuri Hayashi et al. J Thorac Dis. .

Abstract

Background: Transcatheter aortic valve replacement (TAVR) is an effective treatment for aortic valve disorder. Several studies have reported improvements in systolic and diastolic function following TAVR. However, few studies have addressed immediate post-deployment changes. Therefore, this study examines left ventricular (LV) systolic and diastolic function changes immediately after valve deployment in TAVR patients, distinguishing between those with normal and impaired LV ejection fraction (LVEF).

Methods: In this single-center retrospective cohort study, intraoperative changes in LV systolic and diastolic function were analyzed in patients undergoing TAVR from January 2012 to September 2014. Participants were categorized into two groups based on preprocedural LVEF: the low ejection fraction (EF) group (LVEF <50%) and the normal EF group (LVEF ≥50%). LVEF, as an indicator of LV systolic function, along with lateral e' and the E/e' ratio as indicators of LV diastolic function before and immediately after valve deployment were compared in the overall cohort and within each group.

Results: Forty-eight TAVR cases were included, comprising 15 in the low EF group and 33 in the normal EF group. Overall, there was a significant improvement in LVEF {51.7% [standard deviation (SD)] 15.0 vs. 58.0% (SD 11.6), P=0.007}, with no significant changes in e' or E/e'. In the low EF group, a significant increase was observed in LVEF [31.8% (SD 8.0) vs. 45.5% (SD 9.9), P=0.006], e' [5.0 cm/s (SD 1.4) vs. 6.2 cm/s (SD 1.0), P=0.004], and a significant decrease was observed in E/e' [22.3 (SD 7.6) vs. 16.1 (SD 3.4), P=0.01]. The normal EF group showed a significant decrease in e' [6.2 cm/s (SD 1.8) vs. 5.9 cm/s (SD 1.6), P=0.04] without significant changes in LVEF and E/e'.

Conclusions: This study revealed significant intraoperative improvements in systolic and diastolic functions immediately after valve deployment in TAVR patients with low preprocedural LVEF. These immediate improvements were not observed in patients with normal LVEF.

Keywords: Transcatheter aortic valve replacement (TAVR); left ventricular diastolic function; left ventricular systolic function; low ejection fraction.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-784/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Intraoperative assessment of left ventricular diastolic function using mid-esophageal four-chamber view of transesophageal echocardiography. (A) Transmitral flow velocity measured by pulse-wave Doppler echocardiography. E indicates E-wave, representing the peak early transmitral velocity. (B) Mitral annular velocity measured by tissue Doppler imaging. e' represents the early diastolic velocity at the mitral annulus.

Similar articles

References

    1. Muller Moran HR, Eikelboom R, Lodewyks C, et al. Two-year outcomes from the PARTNER 3 trial: where do we stand? Curr Opin Cardiol 2021;36:141-7. 10.1097/HCO.0000000000000813 - DOI - PubMed
    1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med 2023;389:1949-60. 10.1056/NEJMoa2307447 - DOI - PubMed
    1. Muratori M, Fusini L, Tamborini G, et al. Sustained favourable haemodynamics 1 year after TAVI: improvement in NYHA functional class related to improvement of left ventricular diastolic function. Eur Heart J Cardiovasc Imaging 2016;17:1269-78. 10.1093/ehjci/jev306 - DOI - PubMed
    1. Merdler I, Loewenstein I, Hochstadt A, et al. Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis and Variable Ejection Fractions (<40%, 40%-49%, and >50%). Am J Cardiol 2020;125:583-8. 10.1016/j.amjcard.2019.10.059 - DOI - PubMed
    1. Vizzardi E, D'Aloia A, Fiorina C, et al. Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation. J Am Soc Echocardiogr 2012;25:1091-8. 10.1016/j.echo.2012.06.010 - DOI - PubMed

LinkOut - more resources